Ebola

Ebola

Merck to donate Ebola vaccine candidate for research program in Uganda

Merck & Co said on Tuesday it was planning to produce and donate investigational Sudan ebolavirus vaccine to a global non-profit organization's research program in Uganda, which is facing an outbreak of the disease.

This generous donation from Merck will aid in the research efforts to combat the Ebola virus in Uganda and potentially save countless lives. The company's commitment to supporting global health initiatives is commendable and will hopefully lead to significant advancements in the fight against this deadly disease.